Vitamin B12 deficiency symptoms are easy to miss because the first ones rarely look like a vitamin problem.
Numb fingers, unsteady footing, a sore tongue or a fog that sits over concentration all arrive before anaemia does, and often before a routine blood count shows anything at all.[1]
That gap is the reason the UK guideline body NICE published a dedicated guideline on the subject in March 2024, its first.
The document spends more space on recognising the condition and on the limits of the test than on the treatment itself, which tells you where the errors were happening.[1]
Vitamin B12 deficiency symptoms, and where they start
NICE lists cognitive difficulty first: trouble concentrating, short-term memory loss, the state people describe as brain fog. It reads like early dementia and it is sometimes mistaken for it, which matters because this version reverses with treatment and the other does not.[2]
Next come the nerve signs. Pins and needles, numbness, an altered gait, and balance problems caused by losing the sense of where limbs are in space.
Optic nerve involvement can blur vision or cut into the visual field. A smooth, sore tongue is a classic sign that shows up in a minority.[2]
Anaemia and enlarged red cells arrive late in this sequence, not early. Waiting for them before considering the diagnosis is exactly the error the guideline was written to stop, because nerve damage that has been present for many months does not always fully reverse.[1]
Who runs low, and why it takes years to show
The liver holds enough B12 for two to five years, so a shortage builds slowly and rarely has a clear starting point. That storage is also why people can change their diet, feel fine for a long stretch, and then develop symptoms that seem unconnected to anything recent.[7]
Long-term metformin use is the best-documented drug cause. In a multicentre study of community-dwelling adults aged 65 and over taking metformin, 29.4% were deficient, with a median age of 70 and a median nine years of treatment.[4]
A Danish prevalence study of 3,958 people, median age 54, found a much lower 2.3% among current metformin users against 1.3% among non-users. The two figures are not in conflict; they show how sharply the risk rises with age and duration rather than with the drug alone.[5]
Vitamin B12 deficiency symptoms with a normal test result
Total B12 is a late and fairly blunt marker. In a study of a large mixed patient population, the ability to detect subclinical deficiency ranked active B12 highest at an AUC of 0.92, then MMA at 0.91, total B12 at 0.90 and homocysteine at 0.78.
Homocysteine is a second by-product that rises alongside MMA when B12 runs short.[3]
The margins look small, but they sit at the point where decisions are made. A person with early nerve symptoms and a total B12 in the low-normal band is exactly the case where active B12 or MMA changes the answer, and where the standard test alone sends someone home.[3]
NICE now accepts either total B12 or active B12 as the first test, and specifies active B12 in pregnancy and where nitrous oxide use is suspected. The committee noted that in their own experience active B12 is the more accurate of the two.[2]
One rule outranks all of this. Take the blood before starting any replacement. Once supplements begin, every marker moves and the chance to find out what was actually going on is gone for months.[2]
Tablets or injections
About 1% of an oral dose crosses the gut wall by passive diffusion, a route that needs no intrinsic factor and therefore still works when the absorption machinery is broken.
A 1,000 microgram tablet delivers roughly 10 micrograms by that route alone, which is well above daily requirement.[7]
A 2025 systematic review comparing sublingual, oral and intramuscular routes found no significant difference in raising blood levels, and randomised trials have shown comparable haematological recovery on 1,000 to 2,000 micrograms daily.[6]
Injections still have a place where absorption is in doubt, adherence is poor, or neurological signs demand a fast correction. The evidence base for the tablet route is built on blood markers, and blood markers are not the same endpoint as recovery of nerve function.[6]
Where absorption breaks down
B12 in food arrives bound to protein. Stomach acid and enzymes have to release it first. It then has to attach to intrinsic factor, a carrier protein made in the stomach, before the far end of the small intestine can take it up.[7]
Because there are several steps, a blockage at any one of them cuts absorption. Autoimmune gastritis is a condition in which the immune system attacks the stomach lining and reduces the cells that make intrinsic factor.[1]
Eating more does not solve that version of the problem. Removal of the stomach or of the end of the small intestine produces the same result, and long-term acid-suppressing medication weakens the first release step.[7]
Vitamin B12 deficiency symptoms masked by folate
Folate and B12 work together in red cell production, so generous folate can normalise red cell size even while B12 is short. The blood count stops looking abnormal.[7]
The nerves are the problem. Folate does not substitute for B12 in nerve tissue, so the blood picture is corrected while the neurological damage continues. That is why the order of testing is fixed.[7]
B12 status is checked and corrected first, and folate is addressed afterwards. Multivitamins and pre-pregnancy products frequently contain both, which is worth checking on the label.[1]
Plant-based diets, pregnancy and infants
If no animal food is eaten, B12 can only arrive through supplements or fortified products. Some plant milks and cereals are fortified and some are not, so the label rather than the category decides.[7]
Pregnancy adds the share passing to the fetus. NICE specifies active B12 as the initial test during pregnancy precisely because total B12 stops reflecting real status reliably in that period.[2]
A breastfed infant follows the mother directly. If she is short, so is the baby, and the presentation is developmental delay rather than anything that points at a vitamin, which is why these cases take time to identify.[7]
What is still unsettled
There is no agreed cut-off that defines deficiency across laboratories, and reference ranges differ enough that the same sample can be reported as low in one lab and normal in another. Most published prevalence figures are therefore not directly comparable.[3]
Trials measuring nerve recovery rather than blood levels are scarce, so the question of how much neurological damage is reversible after how long remains largely unanswered. Dosing schedules in current use are based on custom more than on trial data.[1]
Iron shortage often travels alongside B12 shortage and produces some of the same tiredness, which is why one is sometimes treated while the other is missed. The dosing evidence for iron turned out to work in the opposite direction from what most people assume.
| Aspect | Finding |
|---|---|
| Earliest symptoms | Concentration and memory difficulty, tingling, numbness, unsteady gait, sore tongue |
| Late symptoms | Anaemia and enlarged red cells; not a screening sign |
| Body stores | Two to five years held in the liver, so onset is slow and undated |
| Metformin, age 65+ | 29.4% deficient, median nine years of use |
| Metformin, median age 54 | 2.3% of users against 1.3% of non-users |
| Best detection score | Active B12 AUC 0.92, MMA 0.91, total B12 0.90, homocysteine 0.78 |
| Oral absorption | About 1% of a dose by passive diffusion, roughly 10 micrograms from a 1,000 microgram tablet |
| Route comparison | No significant difference between sublingual, oral and injected for raising blood levels |
| Order of operations | Draw blood before starting replacement, without exception |
References
- NICE guideline NG239, Vitamin B12 deficiency in over 16s: diagnosis and management. Published 6 March 2024.
- NICE NG239, Recommendations: signs, symptoms and initial testing. 2024.
- Jarquin Campos A, et al. Diagnostic accuracy of holotranscobalamin, vitamin B12, methylmalonic acid and homocysteine in detecting B12 deficiency in a large, mixed patient population. Disease Markers, 2020.
- Vitamin B12 deficiency in metformin-treated community-dwelling older adults with diabetes: a cross-sectional multicentre study. 2025.
- Metformin and vitamin B12 deficiency: a prevalence study. 2026.
- Efficacy of sublingual and oral vitamin B12 versus intramuscular administration: a systematic review and meta-analysis. Frontiers in Pharmacology, 2025.
- Linus Pauling Institute, Micronutrient Information Center: Vitamin B12. Oregon State University.
